Invention Grant
- Patent Title: Dosage regime with esketamine for treating major depressive disorder
-
Application No.: US18193083Application Date: 2023-03-30
-
Publication No.: US12076300B2Publication Date: 2024-09-03
- Inventor: Johanna Schumann , Dorit Mimrod
- Applicant: CLEXIO BIOSCIENCES LTD.
- Applicant Address: IL Jerusalem
- Assignee: CLEXIO BIOSCIENCES LTD.
- Current Assignee: CLEXIO BIOSCIENCES LTD.
- Current Assignee Address: IL Petach Tikva
- Agency: BakerHostetler
- Main IPC: A61K31/135
- IPC: A61K31/135 ; A61K31/137 ; A61K31/138 ; A61K31/15 ; A61K31/343 ; A61K31/381 ; A61K31/4525 ; A61K45/06 ; A61P25/24
Abstract:
The present disclosure provides methods for safe and efficacious administration of esketamine.
Public/Granted literature
- US20230248666A1 DOSAGE REGIME WITH ESKETAMINE FOR TREATING MAJOR DEPRESSIVE DISORDER Public/Granted day:2023-08-10
Information query
